Lotus Health & Wellness

10/12/2026

While women generally exhibit greater longevity than men, they encounter a higher prevalence of chronic conditions, including cardiovascular diseases (CVDs) and various disabilities.
The significant decline in estrogen levels during menopause is correlated with an elevated risk of cardiovascular complications.

Women with CVD risk factors necessitate comprehensive risk stratification to ensure the appropriate selection of type, dosage, and administration route for Menopausal Hormone Therapy (MHT).

Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper - PubMed https://share.google/Wa0dgjo3HZFYnNGz9

10/07/2026

Longevity isn’t built by chasing the newest health trend. It’s built by getting the basics right, knowing what matters, and knowing when to act.

The most powerful tools for a longer, healthier life are often the least complicated: how you sleep, move, eat, manage stress, prevent disease, and stay on top of your health.

Only after the foundation is strong should we start talking about optimization.

Build the foundation first. Then optimize.

10/01/2026

Menopause is one of the most universal experiences in women's health, yet it remains one of the least understood—even among the women going through it.

09/11/2026

FDA Update on Estradiol Transdermal Patch Availability | FDA https://share.google/mgBh6r1f0uetlfYIU

08/24/2026

Lotus Health & Wellness was founded on a simple observation:
the people most likely to be overlooked by conventional medicine are often the ones who look the healthiest. High-functioning individuals showing up for routine visits, told everything looks fine, while quietly running out of resilience, energy, or time to catch problems before they take hold.

Traditional care models weren't built to notice them — not because the medicine was wrong, but because the structure never allowed for the time or depth it takes to look deeper.

We believe healthcare shouldn't wait for a diagnosis to get serious. It should be strategic from the start.

That belief shapes everything about how care is delivered here. Every patient begins with a Foundational Assessment — not a formality, but the groundwork for a real clinical strategy built on data, physiology, and history rather than guesswork. Physician access is protected and unhurried, because prevention and precision both require time conventional visits don't allow. And when complexity does arise, the same rigor that trained our physician in Internal Medicine and Infectious Disease is there to meet it — this isn't wellness in place of medicine, it's medicine practiced the way it should be.

We exist for people who refuse to accept "fine for now" as the ceiling — who want a physician-led partner thinking as far ahead as they are. Not transactional visits. Not trend-driven wellness. A clear, sustained strategy for health, resilience, and the decades still ahead.

08/17/2026

Most bone loss doesn't come with a warning.

By the time a bone density scan flags something, the changes have usually been happening for years — quietly, starting around perimenopause, long before anyone thinks to check.

Same with your heart. Your metabolism. Your brain.

Estrogen doesn't just regulate your cycle. It's protecting systems most women never think to monitor, until they're already changing.

Here's what we actually look at in a Menopause Consultation — most of it, no one's ever offered you before:

Bone density trends + fracture risk
Cardiovascular screening, specific to this hormonal shift
Dementia risk biomarkers
Body composition — muscle, fat, metabolic health (not just weight)
Full hormone panel
Coaching to actually act on what we find

This isn't about fear. It's about seeing it before it's a problem instead of after.

Curious what's actually happening in your body right now? That's what the consultation is for.

Call or text (574)404-3980 to book your first menopause consult.

08/09/2026

Longevity for Men.

S*x hormones could serve as biomarkers for cancer risk.

Lower total testosterone or dihydrotestosterone concentrations in men were associated with a higher risk of cancer death, and mid-range SHBG or LH concentrations were associated with a lower risk. Men with lower SHBG or luteinising hormone concentrations had an associated higher risk of incident prostate cancer.

Lower total testosterone or dihydrotestosterone concentrations in men were associated with a higher risk of cancer death, and mid-range SHBG or luteinising hormone concentrations were associated with a lower risk. Men with lower SHBG or luteinising hormone concentrations had an associated higher ris...

08/04/2026

Comprehensive primary care with an integrative, whole-person approach. Our focus is in evidence based longevity health in men and women.

07/07/2026

06/18/2026